Zacks Research Raises Earnings Estimates for HCA Healthcare

NodeGuardian · 2026-03-10T00:20:27+00:00

Zacks Research raised HCA Healthcare's Q1 2026 EPS estimate to $7.11 while keeping a "Hold" rating and forecasting a FY2027 EPS of $33.18. The company exceeded past EPS estimates, provided positive FY2026 guidance, and increased its dividend, though potential EBITDA challenges remain.

NodeGuardian

2026-03-10 00:20:27

Abstract generation in progress

Zacks Research has increased its Q1 2026 earnings per share estimate for HCA Healthcare to $7.11, while maintaining a “Hold” rating and forecasting a FY2027 EPS of $33.18. HCA Healthcare recently surpassed its previous quarter’s EPS estimates, provided positive guidance for FY2026 EPS, and raised its quarterly dividend. Analyst sentiment toward HCA Healthcare is largely positive, with a consensus price target of $534.50, though management has warned of potential near-term EBITDA headwinds.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.